Trial
NCT03718143
AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
NYU Langone Health
Collaborators
—
Condition
Myelofibroses
Intervention
Combination AZD1775 with AraC
Why stopped
Safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-02